Free Trial

BioHarvest Sciences Q4 2024 Earnings Report

BioHarvest Sciences logo
$5.74 -0.41 (-6.67%)
As of 03:58 PM Eastern

BioHarvest Sciences EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.12
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

BioHarvest Sciences Revenue Results

Actual Revenue
$7.17 million
Expected Revenue
$7.24 million
Beat/Miss
Missed by -$73.00 thousand
YoY Revenue Growth
N/A

BioHarvest Sciences Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Remove Ads

BioHarvest Sciences Earnings Headlines

Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More BioHarvest Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioHarvest Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioHarvest Sciences and other key companies, straight to your email.

About BioHarvest Sciences

BioHarvest Sciences (NASDAQ:BHST) is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

View BioHarvest Sciences Profile

More Earnings Resources from MarketBeat